大博医疗 (002901.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

21.1x

EV/EBITDA

16.9x

Market Cap

CNY 18.84B

MomentumView details →

1D Return

+2.94%

YTD Return

−12.98%

RSI (14)

36.2

ValuationView details →

P/E (Fwd)

21.1x

EV/EBITDA

16.9x

Market Cap

CNY 18.84B

RSI (14)

36.2

MomentumView details →

1D Return

+2.94%

YTD Return

−12.98%

ProfitabilityView details →

Gross Margin

71.55%

Net Margin

23.89%

EBITDA Margin

36.02%

ROE (TTM)

17.27%

ROA (TTM)

12.79%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+19.19%

EPS YoY

+64.19%

FCF YoY

+249.88%

Revenue CAGR 3Y

+21.95%

EPS CAGR 3Y

+88.35%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.51

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.52

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.09x

Current Ratio

4.23x

Quick Ratio

2.71x

Div Yield

1.46%

Div Rate

CNY 0.60

Div Growth 1Y

+20.00%

Financials snapshotView financials →

Revenue (TTM)

2.69B

Net Income (TTM)

643.10M

Op. CF (TTM)

875.77M

Next earningsOct 23, 2026 →

Latest newsMore news →

On August 1, 2026, 47 Chinese A-share companies disclosed various stages of stock buyback progress, including shareholder proposals, initial plans, implementation updates, and completed buybacks.35d ago

Similar companies

东田微301183.SZ 康弘药业002773.SZ 鸿日达301285.SZ 鞍钢股份000898.SZ 珠江啤酒002461.SZ 唯特偶301319.SZ Find similar companies →

Latest newsMore news →

On August 1, 2026, 47 Chinese A-share companies disclosed various stages of stock buyback progress, including shareholder proposals, initial plans, implementation updates, and completed buybacks.35d ago